Studnicka M, Wirnsberger R, Neumann M, Pokieser L, Angerler J
Interne Abteilung, Pulmologischen Zentrum der Stadt Wien, Vienna, Austria.
Chest. 1994 Jun;105(6):1673-8. doi: 10.1378/chest.105.6.1673.
Measurement of lymphocyte subsets in peripheral blood is likely to reflect immune response of patients and therefore may be linked to survival in small-cell lung cancer (SCLC). Forty patients with SCLC (14 with limited and 26 with extensive disease at study entry) were included and followed for up to 23 months. Peripheral blood lymphocytes were determined by flow cytometry and levels for total-, T-, B-, helper-, suppressor-, activated T-cells and natural killer cells established and the T-helper-suppressor ratio (H-S ratio) calculated. Quartiles of lymphocyte subset cell counts at the start of follow-up and for the change over follow-up were investigated. Cox regression models indicated that H-S ratio was a significant predictor (p = 0.02) of survival. The risk ratio, after adjustment for competing risk factors, sex, age and stage of disease, was found to be 0.66 (95 percent confidence intervals, 0.46 to 0.95) and predicted that for each quartile of greater H-S ratio, the risk of death decreased by 34 percent. For change in cell counts over follow-up, total lymphocytes (p = 0.02) demonstrated a significant association with survival. Although our observation is limited by the fact that 13 patients were unavailable for follow-up, we conclude that H-S ratio can serve as an easily accessible marker of immune function and possible prognostic value in SCLC.
外周血淋巴细胞亚群的检测可能反映患者的免疫反应,因此可能与小细胞肺癌(SCLC)的生存率相关。纳入40例SCLC患者(研究入组时14例为局限期,26例为广泛期),随访长达23个月。通过流式细胞术测定外周血淋巴细胞,确定总淋巴细胞、T淋巴细胞、B淋巴细胞、辅助性T细胞、抑制性T细胞、活化T细胞和自然杀伤细胞的水平,并计算T辅助细胞与抑制细胞比值(H-S比值)。研究随访开始时淋巴细胞亚群细胞计数的四分位数以及随访期间的变化情况。Cox回归模型表明,H-S比值是生存的显著预测指标(p = 0.02)。在对竞争风险因素、性别、年龄和疾病分期进行调整后,风险比为0.66(95%置信区间,0.46至0.95),并预测H-S比值每增加一个四分位数,死亡风险降低34%。对于随访期间细胞计数的变化,总淋巴细胞(p = 0.02)与生存显著相关。尽管我们的观察受到13例患者无法进行随访这一事实的限制,但我们得出结论,H-S比值可作为SCLC中易于获得的免疫功能标志物及可能的预后价值指标。